These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 28781146)

  • 1. The impact of FOXO-1 to cardiac pathology in diabetes mellitus and diabetes-related metabolic abnormalities.
    Chistiakov DA; Orekhov AN; Bobryshev YV
    Int J Cardiol; 2017 Oct; 245():236-244. PubMed ID: 28781146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.
    Palomer X; Salvadó L; Barroso E; Vázquez-Carrera M
    Int J Cardiol; 2013 Oct; 168(4):3160-72. PubMed ID: 23932046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of cardiac pathology in diabetes - Experimental insights.
    Varma U; Koutsifeli P; Benson VL; Mellor KM; Delbridge LMD
    Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt B):1949-1959. PubMed ID: 29109032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KLF5 Is Induced by FOXO1 and Causes Oxidative Stress and Diabetic Cardiomyopathy.
    Kyriazis ID; Hoffman M; Gaignebet L; Lucchese AM; Markopoulou E; Palioura D; Wang C; Bannister TD; Christofidou-Solomidou M; Oka SI; Sadoshima J; Koch WJ; Goldberg IJ; Yang VW; Bialkowska AB; Kararigas G; Drosatos K
    Circ Res; 2021 Feb; 128(3):335-357. PubMed ID: 33539225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXO1 contributes to diabetic cardiomyopathy via inducing imbalanced oxidative metabolism in type 1 diabetes.
    Yan D; Cai Y; Luo J; Liu J; Li X; Ying F; Xie X; Xu A; Ma X; Xia Z
    J Cell Mol Med; 2020 Jul; 24(14):7850-7861. PubMed ID: 32450616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic stress-induced activation of FoxO1 triggers diabetic cardiomyopathy in mice.
    Battiprolu PK; Hojayev B; Jiang N; Wang ZV; Luo X; Iglewski M; Shelton JM; Gerard RD; Rothermel BA; Gillette TG; Lavandero S; Hill JA
    J Clin Invest; 2012 Mar; 122(3):1109-18. PubMed ID: 22326951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kir6.1 improves cardiac dysfunction in diabetic cardiomyopathy via the AKT-FoxO1 signalling pathway.
    Wang J; Bai J; Duan P; Wang H; Li Y; Zhu Q
    J Cell Mol Med; 2021 Apr; 25(8):3935-3949. PubMed ID: 33547878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac metabolic modulation upon low-carbohydrate low-protein ketogenic diet in diabetic rats studied in vivo using hyperpolarized
    Abdurrachim D; Teo XQ; Woo CC; Ong SY; Salleh NF; Lalic J; Tan RS; Lee PTH
    Diabetes Obes Metab; 2019 Apr; 21(4):949-960. PubMed ID: 30536560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of MG53 induces diabetic cardiomyopathy through transcriptional activation of peroxisome proliferation-activated receptor α.
    Liu F; Song R; Feng Y; Guo J; Chen Y; Zhang Y; Chen T; Wang Y; Huang Y; Li CY; Cao C; Zhang Y; Hu X; Xiao RP
    Circulation; 2015 Mar; 131(9):795-804. PubMed ID: 25637627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of Foxo1 by insulin resistance promotes cardiac dysfunction and β-myosin heavy chain gene expression.
    Qi Y; Zhu Q; Zhang K; Thomas C; Wu Y; Kumar R; Baker KM; Xu Z; Chen S; Guo S
    Circ Heart Fail; 2015 Jan; 8(1):198-208. PubMed ID: 25477432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of AMP-activated protein kinase on cardio-metabolic abnormalities in the development of diabetic cardiomyopathy: A molecular landscape.
    Haye A; Ansari MA; Rahman SO; Shamsi Y; Ahmed D; Sharma M
    Eur J Pharmacol; 2020 Dec; 888():173376. PubMed ID: 32810493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FoxO1 is crucial for sustaining cardiomyocyte metabolism and cell survival.
    Puthanveetil P; Wan A; Rodrigues B
    Cardiovasc Res; 2013 Mar; 97(3):393-403. PubMed ID: 23263330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of cardiomyocyte proliferation and myocardial growth during development by FOXO transcription factors.
    Evans-Anderson HJ; Alfieri CM; Yutzey KE
    Circ Res; 2008 Mar; 102(6):686-94. PubMed ID: 18218983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibiting microRNA-144 abates oxidative stress and reduces apoptosis in hearts of streptozotocin-induced diabetic mice.
    Yu M; Liu Y; Zhang B; Shi Y; Cui L; Zhao X
    Cardiovasc Pathol; 2015; 24(6):375-81. PubMed ID: 26164195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose radiation prevents type 1 diabetes-induced cardiomyopathy via activation of AKT mediated anti-apoptotic and anti-oxidant effects.
    Zhang F; Lin X; Yu L; Li W; Qian D; Cheng P; He L; Yang H; Zhang C
    J Cell Mol Med; 2016 Jul; 20(7):1352-66. PubMed ID: 26991817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FGF21 deletion exacerbates diabetic cardiomyopathy by aggravating cardiac lipid accumulation.
    Yan X; Chen J; Zhang C; Zhou S; Zhang Z; Chen J; Feng W; Li X; Tan Y
    J Cell Mol Med; 2015 Jul; 19(7):1557-68. PubMed ID: 25823710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salusin-β contributes to oxidative stress and inflammation in diabetic cardiomyopathy.
    Zhao MX; Zhou B; Ling L; Xiong XQ; Zhang F; Chen Q; Li YH; Kang YM; Zhu GQ
    Cell Death Dis; 2017 Mar; 8(3):e2690. PubMed ID: 28333148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Oxidative Stress in Metabolic and Subcellular Abnormalities in Diabetic Cardiomyopathy.
    Dhalla NS; Shah AK; Tappia PS
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel insights into the role of mitochondria in diabetic cardiomyopathy: molecular mechanisms and potential treatments.
    Zhi F; Zhang Q; Liu L; Chang X; Xu H
    Cell Stress Chaperones; 2023 Nov; 28(6):641-655. PubMed ID: 37405612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opening of mitoKATP improves cardiac function and inhibits apoptosis via the AKT-Foxo1 signaling pathway in diabetic cardiomyopathy.
    Duan P; Wang J; Li Y; Wei S; Su F; Zhang S; Duan Y; Wang L; Zhu Q
    Int J Mol Med; 2018 Nov; 42(5):2709-2719. PubMed ID: 30132505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.